Clinigen Group PLC
LSE:CLIN
Clinigen Group PLC
LSE:CLIN
Price:
925 GBX
Market Closed
Updated:
May 26, 2024
Clinigen Group PLC
Cash from Operating Activities
|
Clinigen Group PLC
Cash from Operating Activities Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Clinigen Group PLC
LSE:CLIN
|
Cash from Operating Activities
£45.2m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Cash from Operating Activities
-£137.3m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Cash from Operating Activities
£16m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Cash from Operating Activities
£5.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Cash from Operating Activities
£19.3m
|
CAGR 3-Years
5%
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Cash from Operating Activities
£17.2m
|
CAGR 3-Years
60%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Clinigen Group PLC's Cash from Operating Activities?
Cash from Operating Activities
45.2m
GBP
45.2m
GBP
Based on the financial report for Jun 30, 2021, Clinigen Group PLC's Cash from Operating Activities amounts to 45.2m GBP.
What is Clinigen Group PLC's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
1%
1%
Over the last year, the Cash from Operating Activities growth was -25%. The average annual Cash from Operating Activities growth rates for Clinigen Group PLC have been -2% over the past three years , 1% over the past five years .
You don't have any saved screeners yet
